Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IGC Pharma, Inc. Director's Dealing 2020

Dec 2, 2020

34705_dirs_2020-12-02_53c59e8f-1504-4400-9bb2-cd33308d023c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2020-11-30

Reporting Person: MUKUNDA RAM (Director, Exec. Chairman & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-06-07 Common Stock G 60000 $0.00 Disposed 3364760 Direct
2020-06-07 Common Stock G 60000 $0.00 Disposed 3304760 Direct
2020-11-04 Common Stock G 200000 $0.00 Disposed 3104760 Direct
2020-11-04 Common Stock G 200000 $0.00 Disposed 2904760 Direct
2020-11-30 Common Stock S 80000 $2.3378 Disposed 2824760 Direct